| Issue | Title | |
| Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Antipsychotic Transporter Proteins: A Case Report in a 32-Year-Old Woman with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) |
| S M. Osipova, N. A. Shnayder | ||
| Vol 2, Issue 1 (2022) | Pharmacogenetic Testing of Cytochrome P450 Metabolizing Enzymes in 28-Year-Old Man with Treatment-Resistant Schizophrenia | Abstract PDF (Eng) |
| A. K. Abdyrakhmanova, R. F. Nasyrova | ||
| Vol 2, Issue 2 (2022) | Pharmacogenetic Testing of Cytochrome P450 System Enzymes in the Therapy of Bipolar Affective Disorder | Abstract PDF (Eng) |
| A. K. Khasanova, R. F. Nasyrova | ||
| Vol 6, Issue 2 (2026) | Pharmacogenetically Guided Pharmacotherapy for Alcohol Withdrawal Syndrome Complicated by Seizures: A Pilot Randomized Controlled Trial | Abstract PDF (Eng) |
| Valentin Yu. Skryabin, Svetlana I. Sokolova, Valentina A. Ivanchenko, Alla A. Matskevich, Anton V. Masyakin | ||
| Vol 1, Issue 1 (2021) | Pharmacogenetics of chlorpromazine and its role in the development of antipsychotic-induced parkinsonism | Abstract PDF (Eng) |
| E. E. Vaiman, M. A. Novitsky, R. F. Nasyrova | ||
| Vol 1, Issue 1 (2021) | Pharmacogenetics of fluoxetine | Abstract PDF (Eng) |
| M. A. Novitsky, S. D. Skopin, V. V. Kravtsov | ||
| Vol 1, Issue 1 (2021) | Pharmacogenetics of quetiapine | Abstract PDF (Eng) |
| A. K. Abdyrakhmanova, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| Vol 2, Issue 1 (2022) | Phase I of Antipsychotics Metabolism and its Pharmacogenetic Testing | Abstract PDF (Eng) |
| N. A. Shnayder, A. K. Abdyrakhmanova, R. F. Nasyrova | ||
| Vol 3, Issue 2 (2023) | Phenocopy of Amyotrophic Lateral Sclerosis in Patients with Chiari 1 Malformation Associated Syringomyelia: Brief Literature Review | Abstract PDF (Eng) |
| M. Al-Zamil, N. G. Kulikova | ||
| Vol 1, Issue 2 (2021) | Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia | Abstract PDF (Eng) |
| M. A. Novitsky, A. De Sousa, A. R. Asadullin, O. A. Gavrilyuk, A. V. Petrov, R. F. Nasyrova | ||
| 91 - 100 of 129 Items | << < 5 6 7 8 9 10 11 12 13 > >> | |
Browse Title Index
Popular articles
Vol 2, Issue 1 (2022)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Keywords
Parkinson's disease
adverse drug reaction
adverse drug reactions
adverse reaction
antipsychotic
antipsychotics
biomarkers
candidate genes
clozapine
efficacy
epilepsy
genetics
long QT syndrome
metabolic syndrome
personalized medicine
pharmacogenetic testing
pharmacogenetics
safety
schizophrenia
single nucleotide variant
therapeutic resistance
3, Bekhterev street, bldg. 6, 192019, Saint-Petersburg, Russian Federation
Telephone: +7 (812) 670 02 20, add. 7813, 7814
E-mail: journal.ppnn@gmail.com
